Costa Rica vs Developed regions (Europe, Cyprus, Israel, Northern America, Japan, Australia & New Zealand): Proportion of the target population who received the final dose of

Costa Rica
84.0%
in 2024
Developed regions (Europe, Cyprus, Israel, Northern America, Japan, Australia & New Zealand)
44.0%
in 2024
Costa Rica rank
19th
Developed regions (Europe, Cyprus, Israel, Northern America, Japan, Australia & New Zealand) rank
17th

Proportion of the target population who received the final dose of over time

  • Costa Rica
  • Developed regions (Europe, Cyprus, Israel, Northern America, Japan, Australia & New Zealand)
20406080100201020172024

How they compare

Costa Rica currently reports 84.0% against 44.0% in Developed regions (Europe, Cyprus, Israel, Northern America, Japan, Australia & New Zealand), a difference of 40.0%.

That makes Costa Rica's figure about 1.9 times Developed regions (Europe, Cyprus, Israel, Northern America, Japan, Australia & New Zealand)'s.

Across all 6 years both countries report, Costa Rica has been ahead every year.

Costa Rica ranks 19th and Developed regions (Europe, Cyprus, Israel, Northern America, Japan, Australia & New Zealand) ranks 17th of 107 countries.

Costa Rica has averaged higher in every one of the 2 decades both report.

Head to head by decade

Decade Costa Rica Developed regions (Europe, Cyprus, Israel, Northern America, Japan, Australia & New Zealand) Difference Ahead
2010s 96.0% 40.0% 56.0% Costa Rica
2020s 65.8% 41.4% 24.4% Costa Rica

Averages of every year both report within each decade.

Frequently asked questions

Which has higher proportion of the target population who received the final dose of, Costa Rica or Developed regions (Europe, Cyprus, Israel, Northern America, Japan, Australia & New Zealand)?
Costa Rica, at 84.0% against 44.0% in Developed regions (Europe, Cyprus, Israel, Northern America, Japan, Australia & New Zealand) as of 2024.
What is the difference in proportion of the target population who received the final dose of between Costa Rica and Developed regions (Europe, Cyprus, Israel, Northern America, Japan, Australia & New Zealand)?
40.0%, with Costa Rica ahead.
How many years of comparable data are there for Costa Rica and Developed regions (Europe, Cyprus, Israel, Northern America, Japan, Australia & New Zealand)?
6 years are reported by both, from 2019 to 2024.
How do Costa Rica and Developed regions (Europe, Cyprus, Israel, Northern America, Japan, Australia & New Zealand) rank globally for proportion of the target population who received the final dose of?
Costa Rica ranks 19th and Developed regions (Europe, Cyprus, Israel, Northern America, Japan, Australia & New Zealand) ranks 17th of 107 countries.
Where does this data come from?
United Nations Statistics Division, SDG Global Database, published as Proportion of the target population who received the final dose of human papillomavirus (HPV) vaccine (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.

Individual pages

Share, cite or embed this page

Cite this page

Costa Rica vs Developed regions (Europe, Cyprus, Israel, Northern America, Japan, Australia & New Zealand): Proportion of the target population who received the final dose of. Statizoid, drawing on United Nations Statistics Division, SDG Global Database. Retrieved 19 September 2026, from https://infrastructure.statizoid.com/compare/proportion-of-the-target-population-who-received-the-final-dose-of-human-papillomavirus/costa-rica/developed-regions-europe-cyprus-israel-northern-america-japan-australia-and-new-zealand/

Embed or link this data

Paste this into a page to link back to these figures. The data itself is free to reuse under UN SDG Global Database (open, attribution requested); please keep the attribution.

<a href="https://infrastructure.statizoid.com/compare/proportion-of-the-target-population-who-received-the-final-dose-of-human-papillomavirus/costa-rica/developed-regions-europe-cyprus-israel-northern-america-japan-australia-and-new-zealand/">Costa Rica vs Developed regions (Europe, Cyprus, Israel, Northern America, Japan, Australia & New Zealand): Proportion of the target population who received the final dose of</a> — Statizoid

About this data

Indicator
Proportion of the target population who received the final dose of human papillomavirus (HPV) vaccine (%)
Source
United Nations Statistics Division, SDG Global Database
Licence
UN SDG Global Database (open, attribution requested)
Coverage
142 places, 1,601 data points, 2010–2024
Last refreshed